Sangamo Therapeutics, Inc.

Historical 13F Holders

Symbol
SGMO
CUSIP
800677106
All holders as of
Q4 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 15 987 k $647 k
2024 Q4 139 61.5 M $62.8 M
2024 Q3 115 56.2 M $88.7 M
2024 Q2 136 87.7 M $31.4 M
2024 Q1 139 103 M $69.8 M
2023 Q4 137 89.5 M $48.6 M
2023 Q3 142 104 M $62.2 M
2023 Q2 155 106 M $137 M
2023 Q1 191 114 M $200 M
2022 Q4 195 114 M $357 M
2022 Q3 216 97.8 M $479 M
2022 Q2 200 89.7 M $371 M
2022 Q1 212 81.1 M $472 M
2021 Q4 219 77.4 M $580 M
2021 Q3 216 75.3 M $679 M
2021 Q2 219 76.2 M $912 M
2021 Q1 229 79.4 M $995 M
2020 Q4 261 81.3 M $1.29 B
2020 Q3 232 81.6 M $772 M
2020 Q2 229 77.1 M $691 M
2020 Q1 208 74.6 M $476 M
2019 Q4 213 80.1 M $670 M
2019 Q3 207 84.2 M $766 M
2019 Q2 221 82.0 M $885 M
2019 Q1 210 66.0 M $631 M
2018 Q4 219 65.8 M $755 M
2018 Q3 244 67.3 M $1.14 B
2018 Q2 230 65.5 M $930 M
2018 Q1 224 57.7 M $1.10 B
2017 Q4 188 55.8 M $955 M
2017 Q3 167 54.9 M $823 M
2017 Q2 162 53.0 M $467 M
2017 Q1 131 42.2 M $219 M
2016 Q4 141 41.9 M $128 M
2016 Q3 137 44.0 M $203 M
2016 Q2 148 46.5 M $269 M
2016 Q1 153 48.7 M $292 M
2015 Q4 158 49.1 M $448 M
2015 Q3 154 52.7 M $297 M
2015 Q2 169 50.7 M $562 M
2015 Q1 182 52.7 M $826 M
2014 Q4 174 49.2 M $748 M
2014 Q3 175 48.8 M $527 M
2014 Q2 169 49.7 M $760 M
2014 Q1 160 48.3 M $872 M